Microsoft Cuts Jobs, Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Microsoft Corp MSFT announced a workforce reduction of roughly 10,000 employees amid lease consolidation, which will result in a $1.2 billion charge in Q2.

Microsoft said it will take a series of actions to reinforce its business in response to macro conditions and changing customer priorities. The plans include a workforce reduction and changes to the company's hardware portfolio, as well as lease consolidation.

Microsoft shares fell 1.9% to close at $235.81 on Wednesday, and lost 0.2% in pre-market trading.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

• Guggenheim analyst John Difucci downgraded the stock from Neutral to Sell on Jan. 17, 2023, with a price target of $212. This analyst sees around 10% downside in the company’s stock and has an accuracy rate of 71%.
• Barclays analyst Raimo Lenschow maintained an Overweight rating on Jan. 10, 2023, and cut the price target from $296 to $280. This analyst sees around 19% upside in the company’s stock and has an accuracy rate of 65%.
• Piper Sandler’s analyst Brent Bracelin maintained an Overweight rating on Jan. 9, 2023, and lowered the price target from $265 to $247. This analyst sees around 5% upside in the company’s stock and has an accuracy rate of 69%.
• DA Davidson’s analyst Gil Luria initiated coverage on the stock with a Buy rating on Jan. 5, 2023, with a price target of $270. This analyst sees around 14% upside in the company’s stock and has an accuracy rate of 7%.
• UBS analyst Karl Keirstead downgraded the stock from Buy to Neutral rating on Jan. 4, 2023, and cut the price target from $300 to $250. This analyst sees around 6% upside in the company’s stock and has an accuracy rate of 73%.

Read This Next: Investor Optimism Declines As Nasdaq Snaps 7-Day Win Streak